National Institutes of Health (NIH) NeuroBioBank (NBB) Tissue Toxicology Testing Services
Closed Pre-Solicitation Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75N95024R00082
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Mental Health (NIMH), NeuroBioBank (NBB), has a requirement for tissue toxicology testing services. The purpose is to provide centralized toxicology services to detect the presence and abundance of drugs, therapeutic drugs, and environmental toxins in human postmortem tissues, including brain, blood, and hair, to support biomedical research. The government intends to solicit these services through a request for quotation from National Medical Service (NMS) on a non-competitive basis under simplified acquisition procedures. Responses must include unit price, delivery period, and other key details, and must be received by July 1, 2024.
This is a non-competitive procurement with no set-aside designation. The government plans to award an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to NMS with a 4-year period of performance and a minimum order value of $25,000 and a maximum of $2,984,229. The North American Industry Classification System (NAICS) code is 621511 - Medical Laboratories, with a size standard of $32.5 million.
Notice text
PRE-SOLICITATION NOTICE OF INTENT
NON-COMPETITIVE
Solicitation: 75N95024R00082
Title: National Institutes of Health (NIH) NeuroBioBank (NBB) Tissue Toxicology Testing Services
INTRODUCTION
PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION.
THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH) intends to intends to solicit by a request for quotation from National Medical Service (NMS) for award on or around August 15, 2024. The purpose of this purchase order will be to provide the National Institute of Mental Health (NIMH) with tissue toxicology testing services.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 621511 – Medical Laboratories with a Size Standard of $32.5M.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) in effect through the current Federal Acquisition Circular (FAC).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single Source provides that: For purchases not exceeding the simplified acquisition threshold,
Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).
DESCRIPTION OF REQUIREMENT
Purpose and Objectives
The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute of Mental Health (NIMH), NeuroBioBank (NBB), has a requirement for tissue toxicology testing services.
The National Institutes of Health (NIH) NeuroBioBank (NBB), supported by the National Institute of Mental Health (NIMH), National Institute of Neurological Diseases and Stroke (NINDS), National Institute on Aging (NIA), National Institute on Drug Abuse (NIDA), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is composed of six (6) Brain and Tissue Repositories (BTRs) that are federated through an IT Portal (www.neurobiobank.nih.gov) to increase coordination and sharing of valuable tissue and data resources. Since its inception in 2013, the NIH NBB has sought to identify ways to centralize services to enhance standardization thereby limiting the variability of specimens obtained by different BTRs. One way is to provide centralized toxicology services for all brains acquired by the NBB BTRs.
Delivery or Deliverables
Please see the attached Statement of Work for further details.
CLOSING STATEMENT
THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.www.sam.gov.”
All responses must be received by Monday, July 1, 2024 at 9:00 a.m., Eastern Standard Time, and reference number 75N95024R00082. Responses may be submitted electronically to Robin Knightly, Contract Specialist, at Robin.Knightly@nih.gov.
Fax responses will not be accepted.
Extensions to the deadline will not be granted.
Please contact Robin Knightly, Contract Specialist, at Robin.Knightly@nih.govor (301) 827-5302 with any questions.
Files
| File | Type | Posted |
|---|---|---|
| NBB Toxicology Testing Services - Statement of Work.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| National Institutes of Health (NIH) NeuroBioBank (NBB) Tissue Toxicology Testing Services | Limited / Sole Source Justification | |
| This notice | Pre-Solicitation | |
| National Institutes of Health (NIH) NeuroBioBank (NBB) Tissue Toxicology Testing Services | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business | |
| iPSC Culture and Differentiation | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity